2.5800
+0.0300
+(1.18%)
At close: January 10 at 4:00:02 PM EST
2.5000
-0.08
(-3.10%)
After hours: January 10 at 4:35:17 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 515,940 | 20 |
Sales | 559,036 | 9 |
Net Shares Purchased (Sold) | -43,096 | 29 |
Total Insider Shares Held | 5.55M | -- |
% Net Shares Purchased (Sold) | -0.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
TYREE JAMES L Director | Sale at price 2.46 per share. | Direct | 8,512 | Dec 30, 2024 |
CAPPELLO JOSEPH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 18, 2024 |
ZINDRICK THOMAS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 18, 2024 |
RYDER SEAN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 18, 2024 |
YU YONG Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 18, 2024 |
SMALLING RALPH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 18, 2024 |
ZAK LOURIE S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 18, 2024 |
CAPPELLO JOSEPH Officer | Sale at price 2.34 per share. | Direct | 14,742 | Dec 16, 2024 |
ZINDRICK THOMAS Chief Executive Officer | Sale at price 2.34 per share. | Direct | 33,497 | Dec 16, 2024 |
SMALLING RALPH Officer | Sale at price 2.34 per share. | Direct | 5,873 | Dec 16, 2024 |
ZAK LOURIE S Chief Financial Officer | Sale at price 2.34 per share. | Direct | 4,921 | Dec 16, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.57 - 2.73 per share. | Indirect | 171,678 | Sep 13, 2024 |
TYREE JAMES L Director | Sale at price 2.60 per share. | Direct | 4,499 | Sep 11, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.51 - 2.70 per share. | Indirect | 196,609 | Sep 11, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.09 per share. | Indirect | 89,614 | Sep 3, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.98 - 2.17 per share. | Indirect | 554,411 | Aug 30, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.11 - 2.29 per share. | Indirect | 200,278 | Aug 27, 2024 |
SMITHER JOHN W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
SMITHER JOHN W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
TYREE JAMES L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
TYREE JAMES L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
MIRABELLI MARY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
MIRABELLI MARY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
THOMAS JOHN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
THOMAS JOHN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 1, 2024 |
RYDER SEAN General Counsel | Sale at price 2.12 per share. | Direct | 11,652 | Jun 24, 2024 |
YU YONG Officer | Sale at price 2.12 per share. | Direct | 14,520 | Jun 24, 2024 |
JEWETT CAROLINE Officer | Sale at price 2.12 per share. | Direct | 10,517 | Jun 24, 2024 |
THOMAS JOHN Director | Purchase at price 2.80 per share. | Direct | 7,000 | May 29, 2024 |
SMALLING RALPH Officer | Purchase at price 2.80 per share. | Direct | 3,500 | May 29, 2024 |
ZAK LOURIE S Chief Financial Officer | Purchase at price 2.80 per share. | Direct | 87,500 | May 29, 2024 |
SMITHER JOHN W Director | Purchase at price 2.80 per share. | Direct | 17,500 | May 29, 2024 |
TYREE JAMES L Director | Purchase at price 2.80 per share. | Direct | 17,500 | May 29, 2024 |
ZINDRICK THOMAS Chief Executive Officer | Purchase at price 2.80 per share. | Indirect | 560,000 | May 29, 2024 |
RYDER SEAN General Counsel | Purchase at price 2.80 per share. | Direct | 28,000 | May 29, 2024 |
YU YONG Officer | Purchase at price 2.80 per share. | Direct | 7,000 | May 29, 2024 |
MIRABELLI MARY Director | Purchase at price 2.80 per share. | Direct | 22,400 | May 29, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.58 - 3.66 per share. | Indirect | 130,377 | May 15, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.67 - 3.82 per share. | Indirect | 75,300 | May 8, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.12 - 3.30 per share. | Indirect | 193,934 | May 1, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.49 - 3.53 per share. | Indirect | 155,647 | Apr 24, 2024 |
SZALAY ALADAR Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.53 - 3.71 per share. | Indirect | 256,227 | Apr 17, 2024 |
CAPPELLO JOSEPH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
ZINDRICK THOMAS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
RYDER SEAN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
YU YONG Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
SMALLING RALPH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
JEWETT CAROLINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
ZAK LOURIE S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2024 |
YU YONG Officer | Sale at price 12.94 - 14.18 per share. | Direct | 428,180 | Dec 15, 2023 |
Related Tickers
SABS SAB Biotherapeutics, Inc.
3.8400
-6.80%
AZTR Azitra, Inc.
0.3600
-8.30%
AVTE Aerovate Therapeutics, Inc.
2.5500
-3.41%
ACRV Acrivon Therapeutics, Inc.
5.47
-10.33%
OBIO Orchestra BioMed Holdings, Inc.
5.47
+1.86%
GLYC GlycoMimetics, Inc.
0.2650
-4.26%
ANTX AN2 Therapeutics, Inc.
1.2500
-3.85%
RLYB Rallybio Corporation
0.9400
-5.63%
ERAS Erasca, Inc.
2.3650
-14.00%
PTIX Protagenic Therapeutics, Inc.
0.4800
-14.13%